{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:05Z","timestamp":1789609085807,"version":"build-2803163510"},"reference-count":68,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>Transfusion of D+ red blood cells (RBCs) into D\u2212 recipients, whether through whole blood, RBC, or platelet (PLT) transfusion, can lead to alloimmunization with associated risks of hemolytic reactions from subsequent mismatched transfusion. The incidence of D alloimmunization in various transfused patient populations may be different from that reported in normal subjects or in pregnancy, but prevention of D alloimmunization after mismatched transfusion can be achieved using RhIG. An optimal approach to the use of RhIG, however, has not been identified for the United States. Case histories and studies of volunteers reported over the past 40 years have established that alloimmunization to mismatched RBC transfusion can be successfully prevented with a dose of 20\u2003\u00b5g of RhIG per 1\u2003mL of D+ RBCs (per 2\u2003mL of whole blood) when given within a window of opportunity that extends to at least 72 hours. Evidence from prospective studies of RhIG as a therapy for immune thrombocytopenic purpura suggests that such doses can be tolerably given by intravenous injections over short periods, with adverse event rates minimized when pretransfusion medication is given. For mismatched PLT transfusions, the lowest dose of standard preparations of RhIG (e.g., 125 or 300\u2003\u00b5g) should be sufficient to prevent alloimmunization given the small D+ RBC volumes involved. This article reviews how our understanding of prevention of alloimmunization in mismatched transfusion has progressed over the years and outlines some practical considerations based on the currently available evidence.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.01800.x","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T14:00:04Z","timestamp":1213797604000},"page":"1990-1999","source":"Crossref","is-referenced-by-count":56,"title":["Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG"],"prefix":"10.1111","volume":"48","author":[{"given":"Saleh","family":"Ayache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9]]},"reference":[{"key":"e_1_2_12_2_2","first-page":"385","article-title":"Prevention of Rh immunization after massive Rh\u2010positive transfusion","volume":"99","author":"Bowman JM","year":"1968","journal-title":"Can Med Assoc J"},{"key":"e_1_2_12_3_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4049\/jimmunol.132.2.627","article-title":"Cross\u2010linking of B lymphocyte Fc\u03b3 receptors and membrane immunoglobulin inhibits anti\u2010immunoglobulin\u2010induced blastogenesis","volume":"132","author":"Phillips NE","year":"1984","journal-title":"J Immunol"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.1.5"},{"key":"e_1_2_12_5_2","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.4049\/jimmunol.161.6.2716","article-title":"Superclustering of B cell receptor and Fc\u03b3RIIB1 activates Src homology 2\u2010containing protein tyrosine phosphatase\u20101","volume":"161","author":"Sato K","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_12_6_2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V86.5.1701.bloodjournal8651701","article-title":"Human Rh D monoclonal antibodies (BRAD\u20103 and BRAD\u20105) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D\u2010volunteers","volume":"86","author":"Kumpel BM","year":"1995","journal-title":"Blood"},{"key":"e_1_2_12_7_2","first-page":"565","article-title":"The estimation of the concentration and equilibrium constant of anti\u2010D","volume":"12","author":"Hughes\u2010Jones NC","year":"1967","journal-title":"Immunology"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1957.tb05779.x"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00394.x"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1971.tb04425.x"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1981.21181127486.x"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5696.593"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1972.tb03475.x"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01446.x"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1984.tb01588.x"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1985.tb00167.x"},{"key":"e_1_2_12_17_2","unstructured":"The Royal College of Obstetricians and Gynecologists.Use of anti\u2010D immunoglobulin for Rh prophylaxis. London:Royal College of Obstetricians and Gynaecologists;1999. Revised May 2002. Available fromhttp:\/\/www.rcog.org.uk\/index.asp?PageID=1972"},{"key":"e_1_2_12_18_2","unstructured":"ParkerJ WrayJ GoochA RobsonS Qureshi H for the British Committee for Standards in Haematology.Guidelines for the use of anti\u2010D immunoglobulin for Rh prophylaxis 2006. London:British Committee for Standards in Haematology;2008. Available fromhttp:\/\/www.bcshguidelines.org\/pdf\/Anti\u2010D_070606.pdf"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5336.979"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1964.tb02824.x"},{"key":"e_1_2_12_21_2","first-page":"243","volume-title":"Blood transfusion in clinical medicine","author":"Mollison PL","year":"1993"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1970.tb00722.x"},{"key":"e_1_2_12_23_2","first-page":"293","article-title":"Anti\u2010Rh therapy after transfusion","volume":"8","author":"Keith L","year":"1972","journal-title":"J Reprod Med"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1971.tb04398.x"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(71)90718-6"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1971.tb04424.x"},{"key":"e_1_2_12_27_2","first-page":"349","article-title":"Effect on primary Rh immunization of delayed administration of anti\u2010Rh","volume":"28","author":"Samson D","year":"1975","journal-title":"Immunology"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00319-8"},{"key":"e_1_2_12_29_2","first-page":"1121","article-title":"WinRho: Rh immune globulin prepared by ion exchange for intravenous use","volume":"123","author":"Bowman JM","year":"1980","journal-title":"CMAJ"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2003.00632.x"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.02158.x"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-2977(71)80004-4"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-2977(70)80033-5"},{"key":"e_1_2_12_34_2","volume-title":"Blood transfusion in clinical medicine","author":"Mollison PL","year":"1993"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1104272"},{"key":"e_1_2_12_36_2","first-page":"385","volume-title":"Blood transfusion in clinical medicine","author":"Mollison PL","year":"1983"},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1999.009001093.x"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04131.x"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<245::AID-AJH16>3.0.CO;2-4"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04161.x"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00637.x"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198906000-00015"},{"key":"e_1_2_12_43_2","first-page":"1944","article-title":"Erythrocyte antibodies in liver transplantation: experiences from Huddinge University Hospital","volume":"23","author":"Blomqvist BI","year":"1991","journal-title":"Transplant Proc"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34794330009.x"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00289.x"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.1.3.3"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.9.1884.1884"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200312001-00012"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320381"},{"key":"e_1_2_12_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830220304"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91251-1"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1988.tb00021.x"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00321074"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08142.x"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2689"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.11.019"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02627.x"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4303"},{"key":"e_1_2_12_59_2","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V95.8.2523","article-title":"Acute onset hemoglobineia and\/or hemoglobinuria and sequelae following RhO(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients","volume":"95","author":"Gaines AR","year":"2000","journal-title":"Blood"},{"key":"e_1_2_12_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e318142ac5f"},{"key":"e_1_2_12_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197104292841704"},{"key":"e_1_2_12_62_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28488265260.x"},{"key":"e_1_2_12_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1990.tb00856.x"},{"key":"e_1_2_12_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00074.x"},{"key":"e_1_2_12_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02414.x"},{"key":"e_1_2_12_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00015.x"},{"key":"e_1_2_12_67_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00038.x"},{"key":"e_1_2_12_68_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.351196110898.x"},{"key":"e_1_2_12_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.03370.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.01800.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.01800.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:14:02Z","timestamp":1697256842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.01800.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1537-2995.2008.01800.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01800.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}